Rosaura Esteve-Puig, PhD
|School||UCSF School of Medicine|
|Address||2340 Sutter Street|
San Francisco CA 94115
|University of California San Francisco||Postdoctoral Researcher||Helen Diller Family Comprehensive Cancer Center. Dermatology Department||2012|
|University of Barcelona||PhD in Biomedicine. Thesis title: New evasion mechanism to metabolic stress in melanoma||University of Barcelona- Faculty of Biology||2011|
|University of Barcelona||Master's Degree, Biological and Biomedical Sciences||University of Barcelona. Faculty of Biology -Department of Biochemistry and Molecular Biology||2007|
|Vall d'Hebron Institute of Research||PhD student||University of Barcelona/Vall d'Hebron Institute of Research- Animal Model and Cancer Research||2006|
|Vall d'Hebron Institute of Oncology||Postgraduate Researcher||Growth Factors Laboratory||2005|
|University of Barcelona||Bachelor of Science in Biology Degree||University of Barcelona. Faculty of Biology||2004|
|University of Barcelona||Graduate Student Researcher||University of Barcelona. Faculty of Biology -Department of Cell Biology||2002|
Postdoctoral researcher specializing in cancer biology since 2005.
Pursuing an understanding of tumor molecular mechanisms with the aim of revealing novel clinical therapies.
Expert in signal transduction pathways, protein post translational modifications, long noncoding RNAs and the molecular and cell biology of cancer with a broad range of technical experience including the recently emerged CRISPR/CAS9 system, RNA-protein interaction methods, esiRNA/shRNA technology and molecular cloning.
Contributed missing pieces to the UV-induced DNA damage response pathway, revealed a novel mechanism for the modulation of the ERK pathway signaling by methylation, proposed a new metabolic clinical approach in cancer, and identified and characterized new kinase fusions in spitzoid melanomas.
Cancer, Tranlational Medicine, Signal Transduction, Cancer Cell Signaling, RAS pathway, Cancer Metabolism, noncoding RNA, Mechanisms of Cancer Drug Resistance, Tumor Biology, DNA Damage, CRISPR/CAS9-Targeted genome editing, RNA-protein interactome studies
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.